Medical pathology services
Ended Awarded Last action
- Contract number
- 0002
- Awardee
-
Gen-Probe Incorporated UEI QNXWLAJDL4J3 Part of Hologic, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $650,000
Award facts
- Contract value 100% obligated
- $650,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Bureau of Medicine and Surgery Department of the Navy, Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$650,000 | |
| Other Administrative Action | $650,000 | |
| Funding Only Action | $650,000 | |
| Original award | $0 |
About this award
This is a $650,000.00 Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of the Navy, Bureau of Medicine and Surgery (BUMED) to Gen-Probe Incorporated, a medical diagnostics company specializing in molecular testing systems and assays. The contract is for medical pathology services, including the provision of APTIMA assay test kits for detecting infectious diseases such as HIV, chlamydia, gonorrhea, and COVID-19, as well as PANTHER and PANTHER FUSION automated molecular diagnostic systems and associated reagents and consumables.
This BPA call is part of a larger Indefinite Delivery Contract (IDC) awarded to Gen-Probe by the Defense Health Agency in January 2022, with a $15 million ceiling to provide COVID-19 testing services and supplies. The Department of the Navy Bureau of Medicine and Surgery has also established an IDC with Gen-Probe, valued at $9.6 million, for COVID-19 reagents and assays. These contract vehicles allow the Navy, as well as other defense agencies, to rapidly procure critical molecular diagnostic products from Gen-Probe to support healthcare and pandemic response efforts for military personnel and their families. The contract does not have a set-aside designation, reflecting Gen-Probe's position as a specialized supplier in the molecular diagnostics field.
Quick answers
Who was awarded contract 0002?
0002 was awarded to Gen-Probe Incorporated by Defense Health Agency (Department of Defense) on September 11, 2015.
How much is contract 0002 worth?
The government has obligated $650,000 on 0002.
Which agency awarded contract 0002?
Defense Health Agency (Department of Defense) awarded 0002, with funding from Bureau of Medicine and Surgery (Department of the Navy).
Is contract 0002 an order under another contract?
Yes. 0002 is a BPA call under HT001415A0029, a blanket purchase agreement.
Was contract 0002 competed?
The extent of competition for 0002 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award